nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Mesalazine—PPARG—pancreatic cancer	0.00489	0.517	CrCbGaD
Carbidopa—Epinephrine—TNF—pancreatic cancer	0.0025	0.265	CrCbGaD
Carbidopa—Mesalazine—PTGS2—pancreatic cancer	0.00206	0.218	CrCbGaD
Carbidopa—Mental disorder—Docetaxel—pancreatic cancer	0.00105	0.00106	CcSEcCtD
Carbidopa—Somnolence—Fluorouracil—pancreatic cancer	0.00105	0.00106	CcSEcCtD
Carbidopa—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00105	0.00106	CcSEcCtD
Carbidopa—Decreased appetite—Gemcitabine—pancreatic cancer	0.00105	0.00106	CcSEcCtD
Carbidopa—Dyspepsia—Fluorouracil—pancreatic cancer	0.00104	0.00105	CcSEcCtD
Carbidopa—Nausea—Tamoxifen—pancreatic cancer	0.00104	0.00105	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00104	0.00105	CcSEcCtD
Carbidopa—Fatigue—Gemcitabine—pancreatic cancer	0.00104	0.00105	CcSEcCtD
Carbidopa—Gastritis—Epirubicin—pancreatic cancer	0.00104	0.00105	CcSEcCtD
Carbidopa—Pain—Gemcitabine—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Carbidopa—Constipation—Gemcitabine—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Carbidopa—Nausea—Erlotinib—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Carbidopa—Decreased appetite—Fluorouracil—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Carbidopa—Diarrhoea—Sunitinib—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Carbidopa—Dysgeusia—Docetaxel—pancreatic cancer	0.00103	0.00104	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00102	0.00103	CcSEcCtD
Carbidopa—Ataxia—Doxorubicin—pancreatic cancer	0.00102	0.00103	CcSEcCtD
Carbidopa—Feeling abnormal—Irinotecan—pancreatic cancer	0.00102	0.00103	CcSEcCtD
Carbidopa—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00102	0.00103	CcSEcCtD
Carbidopa—Dysphagia—Epirubicin—pancreatic cancer	0.00101	0.00102	CcSEcCtD
Carbidopa—Back pain—Docetaxel—pancreatic cancer	0.00101	0.00102	CcSEcCtD
Carbidopa—Pain—Fluorouracil—pancreatic cancer	0.00101	0.00102	CcSEcCtD
Carbidopa—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00101	0.00102	CcSEcCtD
Carbidopa—Muscle spasms—Docetaxel—pancreatic cancer	0.00101	0.00102	CcSEcCtD
Carbidopa—Dizziness—Sunitinib—pancreatic cancer	0.000993	0.001	CcSEcCtD
Carbidopa—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000993	0.001	CcSEcCtD
Carbidopa—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000991	0.001	CcSEcCtD
Carbidopa—Body temperature increased—Irinotecan—pancreatic cancer	0.000978	0.000987	CcSEcCtD
Carbidopa—Abdominal pain—Irinotecan—pancreatic cancer	0.000978	0.000987	CcSEcCtD
Carbidopa—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000976	0.000985	CcSEcCtD
Carbidopa—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000971	0.00098	CcSEcCtD
Carbidopa—Anaemia—Docetaxel—pancreatic cancer	0.000968	0.000977	CcSEcCtD
Carbidopa—Gastritis—Doxorubicin—pancreatic cancer	0.000961	0.00097	CcSEcCtD
Carbidopa—Vomiting—Sunitinib—pancreatic cancer	0.000955	0.000964	CcSEcCtD
Carbidopa—Body temperature increased—Gemcitabine—pancreatic cancer	0.000952	0.000961	CcSEcCtD
Carbidopa—Rash—Sunitinib—pancreatic cancer	0.000947	0.000956	CcSEcCtD
Carbidopa—Dermatitis—Sunitinib—pancreatic cancer	0.000946	0.000955	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000942	0.000951	CcSEcCtD
Carbidopa—Urticaria—Fluorouracil—pancreatic cancer	0.000941	0.00095	CcSEcCtD
Carbidopa—Headache—Sunitinib—pancreatic cancer	0.00094	0.000949	CcSEcCtD
Carbidopa—Syncope—Docetaxel—pancreatic cancer	0.000939	0.000948	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—pancreatic cancer	0.000938	0.000947	CcSEcCtD
Carbidopa—Leukopenia—Docetaxel—pancreatic cancer	0.000938	0.000947	CcSEcCtD
Carbidopa—Pollakiuria—Epirubicin—pancreatic cancer	0.000937	0.000946	CcSEcCtD
Carbidopa—Body temperature increased—Fluorouracil—pancreatic cancer	0.000936	0.000945	CcSEcCtD
Carbidopa—Palpitations—Docetaxel—pancreatic cancer	0.000926	0.000934	CcSEcCtD
Carbidopa—Weight increased—Epirubicin—pancreatic cancer	0.000923	0.000932	CcSEcCtD
Carbidopa—Loss of consciousness—Docetaxel—pancreatic cancer	0.000921	0.000929	CcSEcCtD
Carbidopa—Weight decreased—Epirubicin—pancreatic cancer	0.000917	0.000926	CcSEcCtD
Carbidopa—Cough—Docetaxel—pancreatic cancer	0.000914	0.000923	CcSEcCtD
Carbidopa—Hypersensitivity—Irinotecan—pancreatic cancer	0.000911	0.00092	CcSEcCtD
Carbidopa—Convulsion—Docetaxel—pancreatic cancer	0.000908	0.000916	CcSEcCtD
Carbidopa—Hypertension—Docetaxel—pancreatic cancer	0.000904	0.000913	CcSEcCtD
Carbidopa—Chest pain—Docetaxel—pancreatic cancer	0.000892	0.0009	CcSEcCtD
Carbidopa—Nausea—Sunitinib—pancreatic cancer	0.000892	0.0009	CcSEcCtD
Carbidopa—Asthenia—Irinotecan—pancreatic cancer	0.000887	0.000896	CcSEcCtD
Carbidopa—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000886	0.000895	CcSEcCtD
Carbidopa—Urinary tract infection—Epirubicin—pancreatic cancer	0.000879	0.000887	CcSEcCtD
Carbidopa—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000873	0.000881	CcSEcCtD
Carbidopa—Dry mouth—Docetaxel—pancreatic cancer	0.000872	0.00088	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000872	0.00088	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—pancreatic cancer	0.000867	0.000875	CcSEcCtD
Carbidopa—Asthenia—Gemcitabine—pancreatic cancer	0.000864	0.000873	CcSEcCtD
Carbidopa—Confusional state—Docetaxel—pancreatic cancer	0.000862	0.00087	CcSEcCtD
Carbidopa—Oedema—Docetaxel—pancreatic cancer	0.000855	0.000863	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—pancreatic cancer	0.000854	0.000862	CcSEcCtD
Carbidopa—Pruritus—Gemcitabine—pancreatic cancer	0.000852	0.00086	CcSEcCtD
Carbidopa—Infection—Docetaxel—pancreatic cancer	0.000849	0.000857	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—pancreatic cancer	0.000849	0.000857	CcSEcCtD
Carbidopa—Diarrhoea—Irinotecan—pancreatic cancer	0.000846	0.000854	CcSEcCtD
Carbidopa—Agranulocytosis—Epirubicin—pancreatic cancer	0.000844	0.000852	CcSEcCtD
Carbidopa—Shock—Docetaxel—pancreatic cancer	0.000841	0.000849	CcSEcCtD
Carbidopa—Pruritus—Fluorouracil—pancreatic cancer	0.000838	0.000846	CcSEcCtD
Carbidopa—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000837	0.000845	CcSEcCtD
Carbidopa—Diarrhoea—Gemcitabine—pancreatic cancer	0.000824	0.000832	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.00082	0.000828	CcSEcCtD
Carbidopa—Dizziness—Irinotecan—pancreatic cancer	0.000818	0.000826	CcSEcCtD
Carbidopa—Haemoglobin—Epirubicin—pancreatic cancer	0.000816	0.000823	CcSEcCtD
Carbidopa—Anorexia—Docetaxel—pancreatic cancer	0.000815	0.000823	CcSEcCtD
Carbidopa—Rhinitis—Epirubicin—pancreatic cancer	0.000814	0.000821	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000813	0.000821	CcSEcCtD
Carbidopa—Haemorrhage—Epirubicin—pancreatic cancer	0.000812	0.000819	CcSEcCtD
Carbidopa—Diarrhoea—Fluorouracil—pancreatic cancer	0.00081	0.000818	CcSEcCtD
Carbidopa—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000808	0.000815	CcSEcCtD
Carbidopa—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000801	0.000809	CcSEcCtD
Carbidopa—Hypotension—Docetaxel—pancreatic cancer	0.000799	0.000806	CcSEcCtD
Carbidopa—Urethral disorder—Epirubicin—pancreatic cancer	0.000796	0.000803	CcSEcCtD
Carbidopa—Vomiting—Irinotecan—pancreatic cancer	0.000786	0.000794	CcSEcCtD
Carbidopa—Dizziness—Fluorouracil—pancreatic cancer	0.000783	0.000791	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000781	0.000788	CcSEcCtD
Carbidopa—Rash—Irinotecan—pancreatic cancer	0.00078	0.000787	CcSEcCtD
Carbidopa—Dermatitis—Irinotecan—pancreatic cancer	0.000779	0.000786	CcSEcCtD
Carbidopa—Headache—Irinotecan—pancreatic cancer	0.000775	0.000782	CcSEcCtD
Carbidopa—Insomnia—Docetaxel—pancreatic cancer	0.000773	0.000781	CcSEcCtD
Carbidopa—Paraesthesia—Docetaxel—pancreatic cancer	0.000768	0.000775	CcSEcCtD
Carbidopa—Vomiting—Gemcitabine—pancreatic cancer	0.000766	0.000773	CcSEcCtD
Carbidopa—Dyspnoea—Docetaxel—pancreatic cancer	0.000762	0.000769	CcSEcCtD
Carbidopa—Somnolence—Docetaxel—pancreatic cancer	0.00076	0.000767	CcSEcCtD
Carbidopa—Rash—Gemcitabine—pancreatic cancer	0.00076	0.000767	CcSEcCtD
Carbidopa—Dermatitis—Gemcitabine—pancreatic cancer	0.000759	0.000766	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—pancreatic cancer	0.000755	0.000762	CcSEcCtD
Carbidopa—Headache—Gemcitabine—pancreatic cancer	0.000755	0.000762	CcSEcCtD
Carbidopa—Flushing—Epirubicin—pancreatic cancer	0.000753	0.00076	CcSEcCtD
Carbidopa—Vomiting—Fluorouracil—pancreatic cancer	0.000753	0.00076	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—pancreatic cancer	0.000753	0.00076	CcSEcCtD
Carbidopa—Dyspepsia—Docetaxel—pancreatic cancer	0.000752	0.00076	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—pancreatic cancer	0.000751	0.000758	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000747	0.000754	CcSEcCtD
Carbidopa—Rash—Fluorouracil—pancreatic cancer	0.000747	0.000754	CcSEcCtD
Carbidopa—Dermatitis—Fluorouracil—pancreatic cancer	0.000746	0.000753	CcSEcCtD
Carbidopa—Decreased appetite—Docetaxel—pancreatic cancer	0.000743	0.00075	CcSEcCtD
Carbidopa—Headache—Fluorouracil—pancreatic cancer	0.000742	0.000749	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000742	0.000749	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000738	0.000745	CcSEcCtD
Carbidopa—Fatigue—Docetaxel—pancreatic cancer	0.000737	0.000744	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—pancreatic cancer	0.000736	0.000743	CcSEcCtD
Carbidopa—Nausea—Irinotecan—pancreatic cancer	0.000735	0.000742	CcSEcCtD
Carbidopa—Pain—Docetaxel—pancreatic cancer	0.000731	0.000738	CcSEcCtD
Carbidopa—Constipation—Docetaxel—pancreatic cancer	0.000731	0.000738	CcSEcCtD
Carbidopa—Alopecia—Epirubicin—pancreatic cancer	0.000717	0.000724	CcSEcCtD
Carbidopa—Nausea—Gemcitabine—pancreatic cancer	0.000716	0.000722	CcSEcCtD
Carbidopa—Mental disorder—Epirubicin—pancreatic cancer	0.000711	0.000718	CcSEcCtD
Carbidopa—Feeling abnormal—Docetaxel—pancreatic cancer	0.000704	0.000711	CcSEcCtD
Carbidopa—Nausea—Fluorouracil—pancreatic cancer	0.000704	0.00071	CcSEcCtD
Carbidopa—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000699	0.000706	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—pancreatic cancer	0.000697	0.000704	CcSEcCtD
Carbidopa—Flatulence—Epirubicin—pancreatic cancer	0.000696	0.000703	CcSEcCtD
Carbidopa—Tension—Epirubicin—pancreatic cancer	0.000693	0.0007	CcSEcCtD
Carbidopa—Dysgeusia—Epirubicin—pancreatic cancer	0.000692	0.000698	CcSEcCtD
Carbidopa—Nervousness—Epirubicin—pancreatic cancer	0.000686	0.000693	CcSEcCtD
Carbidopa—Back pain—Epirubicin—pancreatic cancer	0.000683	0.00069	CcSEcCtD
Carbidopa—Muscle spasms—Epirubicin—pancreatic cancer	0.000679	0.000686	CcSEcCtD
Carbidopa—Abdominal pain—Docetaxel—pancreatic cancer	0.000676	0.000682	CcSEcCtD
Carbidopa—Body temperature increased—Docetaxel—pancreatic cancer	0.000676	0.000682	CcSEcCtD
Carbidopa—Vision blurred—Epirubicin—pancreatic cancer	0.000666	0.000672	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—pancreatic cancer	0.000664	0.00067	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—pancreatic cancer	0.000658	0.000664	CcSEcCtD
Carbidopa—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000656	0.000662	CcSEcCtD
Carbidopa—Anaemia—Epirubicin—pancreatic cancer	0.000653	0.000659	CcSEcCtD
Carbidopa—Agitation—Epirubicin—pancreatic cancer	0.000649	0.000655	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—pancreatic cancer	0.000644	0.00065	CcSEcCtD
Carbidopa—Tension—Doxorubicin—pancreatic cancer	0.000641	0.000648	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—pancreatic cancer	0.00064	0.000646	CcSEcCtD
Carbidopa—Malaise—Epirubicin—pancreatic cancer	0.000637	0.000643	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—pancreatic cancer	0.000635	0.000641	CcSEcCtD
Carbidopa—Syncope—Epirubicin—pancreatic cancer	0.000634	0.00064	CcSEcCtD
Carbidopa—Leukopenia—Epirubicin—pancreatic cancer	0.000632	0.000638	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—pancreatic cancer	0.000632	0.000638	CcSEcCtD
Carbidopa—Hypersensitivity—Docetaxel—pancreatic cancer	0.00063	0.000636	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—pancreatic cancer	0.000628	0.000634	CcSEcCtD
Carbidopa—Palpitations—Epirubicin—pancreatic cancer	0.000624	0.00063	CcSEcCtD
Carbidopa—Loss of consciousness—Epirubicin—pancreatic cancer	0.000621	0.000627	CcSEcCtD
Carbidopa—Cough—Epirubicin—pancreatic cancer	0.000616	0.000622	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—pancreatic cancer	0.000616	0.000622	CcSEcCtD
Carbidopa—Asthenia—Docetaxel—pancreatic cancer	0.000613	0.000619	CcSEcCtD
Carbidopa—Convulsion—Epirubicin—pancreatic cancer	0.000612	0.000618	CcSEcCtD
Carbidopa—Hypertension—Epirubicin—pancreatic cancer	0.00061	0.000616	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000607	0.000612	CcSEcCtD
Carbidopa—Pruritus—Docetaxel—pancreatic cancer	0.000605	0.000611	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—pancreatic cancer	0.000604	0.00061	CcSEcCtD
Carbidopa—Chest pain—Epirubicin—pancreatic cancer	0.000601	0.000607	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—pancreatic cancer	0.000601	0.000606	CcSEcCtD
Carbidopa—Anxiety—Epirubicin—pancreatic cancer	0.000599	0.000605	CcSEcCtD
Carbidopa—Discomfort—Epirubicin—pancreatic cancer	0.000594	0.0006	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—pancreatic cancer	0.000589	0.000595	CcSEcCtD
Carbidopa—Dry mouth—Epirubicin—pancreatic cancer	0.000588	0.000594	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—pancreatic cancer	0.000586	0.000592	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—pancreatic cancer	0.000585	0.000591	CcSEcCtD
Carbidopa—Diarrhoea—Docetaxel—pancreatic cancer	0.000585	0.00059	CcSEcCtD
Carbidopa—Confusional state—Epirubicin—pancreatic cancer	0.000581	0.000587	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—pancreatic cancer	0.000578	0.000583	CcSEcCtD
Carbidopa—Oedema—Epirubicin—pancreatic cancer	0.000577	0.000582	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000575	0.00058	CcSEcCtD
Carbidopa—Infection—Epirubicin—pancreatic cancer	0.000573	0.000578	CcSEcCtD
Carbidopa—Cough—Doxorubicin—pancreatic cancer	0.00057	0.000576	CcSEcCtD
Carbidopa—Shock—Epirubicin—pancreatic cancer	0.000567	0.000573	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—pancreatic cancer	0.000566	0.000572	CcSEcCtD
Carbidopa—Dizziness—Docetaxel—pancreatic cancer	0.000565	0.000571	CcSEcCtD
Carbidopa—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000565	0.00057	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—pancreatic cancer	0.000564	0.00057	CcSEcCtD
Carbidopa—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000557	0.000563	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—pancreatic cancer	0.000557	0.000562	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—pancreatic cancer	0.000555	0.00056	CcSEcCtD
Carbidopa—Discomfort—Doxorubicin—pancreatic cancer	0.00055	0.000555	CcSEcCtD
Carbidopa—Anorexia—Epirubicin—pancreatic cancer	0.00055	0.000555	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—pancreatic cancer	0.000544	0.000549	CcSEcCtD
Carbidopa—Vomiting—Docetaxel—pancreatic cancer	0.000544	0.000549	CcSEcCtD
Carbidopa—Rash—Docetaxel—pancreatic cancer	0.000539	0.000544	CcSEcCtD
Carbidopa—Hypotension—Epirubicin—pancreatic cancer	0.000539	0.000544	CcSEcCtD
Carbidopa—Dermatitis—Docetaxel—pancreatic cancer	0.000538	0.000544	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—pancreatic cancer	0.000538	0.000543	CcSEcCtD
Carbidopa—Headache—Docetaxel—pancreatic cancer	0.000536	0.000541	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—pancreatic cancer	0.000534	0.000539	CcSEcCtD
Carbidopa—Infection—Doxorubicin—pancreatic cancer	0.00053	0.000535	CcSEcCtD
Carbidopa—Shock—Doxorubicin—pancreatic cancer	0.000525	0.00053	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000522	0.000527	CcSEcCtD
Carbidopa—Insomnia—Epirubicin—pancreatic cancer	0.000521	0.000526	CcSEcCtD
Carbidopa—Paraesthesia—Epirubicin—pancreatic cancer	0.000518	0.000523	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000516	0.000521	CcSEcCtD
Carbidopa—Dyspnoea—Epirubicin—pancreatic cancer	0.000514	0.000519	CcSEcCtD
Carbidopa—Somnolence—Epirubicin—pancreatic cancer	0.000513	0.000517	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—pancreatic cancer	0.000509	0.000513	CcSEcCtD
Carbidopa—Nausea—Docetaxel—pancreatic cancer	0.000508	0.000513	CcSEcCtD
Carbidopa—Dyspepsia—Epirubicin—pancreatic cancer	0.000508	0.000512	CcSEcCtD
Carbidopa—Decreased appetite—Epirubicin—pancreatic cancer	0.000501	0.000506	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—pancreatic cancer	0.000499	0.000503	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000498	0.000503	CcSEcCtD
Carbidopa—Fatigue—Epirubicin—pancreatic cancer	0.000497	0.000502	CcSEcCtD
Carbidopa—Constipation—Epirubicin—pancreatic cancer	0.000493	0.000498	CcSEcCtD
Carbidopa—Pain—Epirubicin—pancreatic cancer	0.000493	0.000498	CcSEcCtD
Carbidopa—Insomnia—Doxorubicin—pancreatic cancer	0.000483	0.000487	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—pancreatic cancer	0.000479	0.000484	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—pancreatic cancer	0.000476	0.00048	CcSEcCtD
Carbidopa—Feeling abnormal—Epirubicin—pancreatic cancer	0.000475	0.00048	CcSEcCtD
Carbidopa—Somnolence—Doxorubicin—pancreatic cancer	0.000474	0.000479	CcSEcCtD
Carbidopa—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000471	0.000476	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—pancreatic cancer	0.00047	0.000474	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—pancreatic cancer	0.000464	0.000468	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000461	0.000465	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—pancreatic cancer	0.00046	0.000464	CcSEcCtD
Carbidopa—Urticaria—Epirubicin—pancreatic cancer	0.000458	0.000462	CcSEcCtD
Carbidopa—Pain—Doxorubicin—pancreatic cancer	0.000456	0.000461	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—pancreatic cancer	0.000456	0.000461	CcSEcCtD
Carbidopa—Abdominal pain—Epirubicin—pancreatic cancer	0.000456	0.00046	CcSEcCtD
Carbidopa—Body temperature increased—Epirubicin—pancreatic cancer	0.000456	0.00046	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00044	0.000444	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000436	0.00044	CcSEcCtD
Carbidopa—Hypersensitivity—Epirubicin—pancreatic cancer	0.000425	0.000429	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—pancreatic cancer	0.000424	0.000428	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—pancreatic cancer	0.000422	0.000426	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—pancreatic cancer	0.000422	0.000426	CcSEcCtD
Carbidopa—Asthenia—Epirubicin—pancreatic cancer	0.000414	0.000418	CcSEcCtD
Carbidopa—Pruritus—Epirubicin—pancreatic cancer	0.000408	0.000412	CcSEcCtD
Carbidopa—Diarrhoea—Epirubicin—pancreatic cancer	0.000395	0.000398	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000393	0.000397	CcSEcCtD
Carbidopa—Asthenia—Doxorubicin—pancreatic cancer	0.000383	0.000386	CcSEcCtD
Carbidopa—Dizziness—Epirubicin—pancreatic cancer	0.000381	0.000385	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—pancreatic cancer	0.000377	0.000381	CcSEcCtD
Carbidopa—Vomiting—Epirubicin—pancreatic cancer	0.000367	0.00037	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—pancreatic cancer	0.000365	0.000369	CcSEcCtD
Carbidopa—Rash—Epirubicin—pancreatic cancer	0.000364	0.000367	CcSEcCtD
Carbidopa—Dermatitis—Epirubicin—pancreatic cancer	0.000363	0.000367	CcSEcCtD
Carbidopa—Headache—Epirubicin—pancreatic cancer	0.000361	0.000365	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—pancreatic cancer	0.000353	0.000356	CcSEcCtD
Carbidopa—Nausea—Epirubicin—pancreatic cancer	0.000342	0.000346	CcSEcCtD
Carbidopa—Vomiting—Doxorubicin—pancreatic cancer	0.000339	0.000342	CcSEcCtD
Carbidopa—Rash—Doxorubicin—pancreatic cancer	0.000336	0.00034	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—pancreatic cancer	0.000336	0.000339	CcSEcCtD
Carbidopa—Headache—Doxorubicin—pancreatic cancer	0.000334	0.000337	CcSEcCtD
Carbidopa—Nausea—Doxorubicin—pancreatic cancer	0.000317	0.00032	CcSEcCtD
